Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Comparative Proteomics of Enterotoxigenic Escherichia coli Reveals Differences in Surface Protein Production and Similarities in Metabolism.

Pettersen VK, Steinsland H, Wiker HG.

J Proteome Res. 2018 Jan 5;17(1):325-336. doi: 10.1021/acs.jproteome.7b00593. Epub 2017 Dec 12.

PMID:
29185342
2.

Protected sampling is preferable in bronchoscopic studies of the airway microbiome.

Grønseth R, Drengenes C, Wiker HG, Tangedal S, Xue Y, Husebø GR, Svanes Ø, Lehmann S, Aardal M, Hoang T, Kalananthan T, Hjellestad Martinsen EM, Orvedal Leiten E, Aanerud M, Nordeide E, Haaland I, Jonassen I, Bakke P, Eagan T.

ERJ Open Res. 2017 Aug 30;3(3). pii: 00019-2017. doi: 10.1183/23120541.00019-2017. eCollection 2017 Jul.

3.

Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.

Tangedal S, Aanerud M, Grønseth R, Drengenes C, Wiker HG, Bakke PS, Eagan TM.

Respir Res. 2017 Aug 29;18(1):164. doi: 10.1186/s12931-017-0645-3.

4.

Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.

Mohammed MMA, Pettersen VK, Nerland AH, Wiker HG, Bakken V.

Anaerobe. 2017 Apr;44:133-142. doi: 10.1016/j.anaerobe.2017.03.002. Epub 2017 Mar 9.

PMID:
28285095
5.

Zoonotic necrotizing myositis caused by Streptococcus equi subsp. zooepidemicus in a farmer.

Kittang BR, Pettersen VK, Oppegaard O, Skutlaberg DH, Dale H, Wiker HG, Skrede S.

BMC Infect Dis. 2017 Feb 15;17(1):147. doi: 10.1186/s12879-017-2262-7.

6.

Coordination of Metabolism and Virulence Factors Expression of Extraintestinal Pathogenic Escherichia coli Purified from Blood Cultures of Patients with Sepsis.

Pettersen VK, Mosevoll KA, Lindemann PC, Wiker HG.

Mol Cell Proteomics. 2016 Sep;15(9):2890-907. doi: 10.1074/mcp.M116.060582. Epub 2016 Jun 30.

7.

Improving genome annotation of enterotoxigenic Escherichia coli TW10598 by a label-free quantitative MS/MS approach.

Pettersen VK, Steinsland H, Wiker HG.

Proteomics. 2015 Nov;15(22):3826-34. doi: 10.1002/pmic.201500278. Epub 2015 Oct 7.

PMID:
26349841
8.

Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients.

Mustafa T, Brokstad KA, Mfinanga SG, Wiker HG.

Tuberc Res Treat. 2015;2015:561490. doi: 10.1155/2015/561490. Epub 2015 Apr 28.

9.

Diffusion blotting: a rapid and simple method for production of multiple blots from a single gel.

Olsen I, Wiker HG.

Methods Mol Biol. 2015;1312:73-6. doi: 10.1007/978-1-4939-2694-7_10.

PMID:
26043991
10.

Phosphoproteomics analysis of a clinical Mycobacterium tuberculosis Beijing isolate: expanding the mycobacterial phosphoproteome catalog.

Fortuin S, Tomazella GG, Nagaraj N, Sampson SL, Gey van Pittius NC, Soares NC, Wiker HG, de Souza GA, Warren RM.

Front Microbiol. 2015 Feb 10;6:6. doi: 10.3389/fmicb.2015.00006. eCollection 2015.

11.

Effect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management.

Dhanasekaran S, Jenum S, Stavrum R, Wiker HG, Kenneth J, Vaz M, Doherty TM, Grewal HM; TB Trials Study Group.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3243. doi: 10.1371/journal.pntd.0003243. eCollection 2014 Oct.

12.

Differential in vivo expression of mycobacterial antigens in Mycobacterium tuberculosis infected lungs and lymph node tissues.

Mustafa T, Leversen NA, Sviland L, Wiker HG.

BMC Infect Dis. 2014 Oct 3;14:535. doi: 10.1186/1471-2334-14-535.

13.

Proteogenomics in microbiology: taking the right turn at the junction of genomics and proteomics.

Kucharova V, Wiker HG.

Proteomics. 2014 Dec;14(23-24):2360-675. doi: 10.1002/pmic.201400168. Epub 2014 Nov 19.

PMID:
25263021
14.

The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences.

Grønseth R, Haaland I, Wiker HG, Martinsen EM, Leiten EO, Husebø G, Svanes Ø, Bakke PS, Eagan TM.

Eur Clin Respir J. 2014 Dec 29;1. doi: 10.3402/ecrj.v1.26196. eCollection 2014.

15.

Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.

Lindemann PC, Risberg K, Wiker HG, Mylvaganam H.

APMIS. 2012 Jun;120(6):495-502. doi: 10.1111/j.1600-0463.2011.02856.x. Epub 2011 Dec 19.

PMID:
22583362
16.

Improved signal peptide predictions in mycobacteria?

Leversen NA, Wiker HG.

Tuberculosis (Edinb). 2012 Jul;92(4):291-2. doi: 10.1016/j.tube.2012.03.002. Epub 2012 Apr 7. No abstract available.

PMID:
22484109
17.

Dual priming oligonucleotides for broad-range amplification of the bacterial 16S rRNA gene directly from human clinical specimens.

Kommedal Ø, Simmon K, Karaca D, Langeland N, Wiker HG.

J Clin Microbiol. 2012 Apr;50(4):1289-94. doi: 10.1128/JCM.06269-11. Epub 2012 Jan 25.

18.

Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection.

Leversen NA, Sviland L, Wiker HG, Mustafa T.

Scand J Immunol. 2012 May;75(5):489-99. doi: 10.1111/j.1365-3083.2012.02683.x.

19.

Proteomic analysis of a multi-resistant clinical Escherichia coli isolate of unknown genomic background.

Tomazella GG, Risberg K, Mylvaganam H, Lindemann PC, Thiede B, Souza GA, Wiker HG.

J Proteomics. 2012 Mar 16;75(6):1830-7. doi: 10.1016/j.jprot.2011.12.024. Epub 2011 Dec 30.

PMID:
22236517
20.

Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway.

de Souza GA, Leversen NA, Målen H, Wiker HG.

J Proteomics. 2011 Dec 21;75(2):502-10. doi: 10.1016/j.jprot.2011.08.016. Epub 2011 Sep 5.

Supplemental Content

Loading ...
Support Center